Squalamine inhibits angiogenesis and solid tumor growth in vivo and perturbs embryonic vasculature

Cancer Research

Volumn 58, Issue 13, 1998, Pages 2784-2792

  Sills Jr , Allen K ^a   Williams, Jon I ^d   Tyler, Betty M ^a   Epstein, Darin S ^a   Sipos, Eric P ^a   Davis, John D ^a   McLane, Michael P ^d   Pitchford, Simon ^b   Cheshire, Kimberly ^d   Gannon, Francis H ^c   Kinney, William A ^d   Chao, Tessa L ^d   Donowitz, Mark ^a   Laterra, John ^a   Zasloff, Michael ^d   Brem, Henry ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MOLECULAR DEVICES CORPORATION   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^d Genaera Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BASIC FIBROBLAST GROWTH FACTOR; CHOLESTANE DERIVATIVE; SQUALAMINE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CHICKEN; CONTROLLED STUDY; CORNEA; CYTOTOXICITY; DRUG ACTIVITY; DRUG EFFICACY; ENDOTHELIUM CELL; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SOLID TUMOR; TERATOGENESIS; TUMOR GROWTH;

ANIMALS; ANTICARCINOGENIC AGENTS; CELL DIVISION; CELL MOVEMENT; CHICK EMBRYO; CHOLESTANOLS; COLLAGEN; CORNEA; CORNEAL NEOVASCULARIZATION; DRUG COMBINATIONS; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; EYE NEOPLASMS; FIBROBLAST GROWTH FACTOR 2; GLIOMA; LAMININ; LYMPHOKINES; MICE; MICE, INBRED BALB C; NEOVASCULARIZATION, PHYSIOLOGIC; PLATELET-DERIVED GROWTH FACTOR; PROTEOGLYCANS; RABBITS; RATS; RATS, INBRED F344; TRANSPLANTATION, HETEROLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 15644374381     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Miller, J. W., Adamis, A. P., Shima, D. T., D'Amore, P. A., Moulton, R. S., O'Reilly, M. S., Folkman, J., Dvorak, H. F., Brown, L. F., Berse, B., et al. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am. J. Pathol., 145: 574-584, 1994.
2. Folkman, J. Angiogenesis and its inhibitors. In: V. Devita, S. Hellman, and S. Rosenberg (eds.), Important Advances in Oncology, pp. 42-62. Philadelphia: J. B. Lippincott, 1985.
3. D'Amore, P. A., and Thompson, R. W. Mechanisms of angiogenesis. Annu. Rev. Physiol., 49: 453-464, 1987.
4. Bacharach, E., Itin, A., and Keshet, E. In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis, Proc. Natl. Acad. Sci. USA, 89: 10686-10690, 1992.
5. Folkman, J., and Klagsburn, M. Angiogenic factors. Science (Washington DC), 235: 442-447, 1987.
6. Gimbrone, M. A., Jr., Leapman, S. B., Cotran, R. S., and Folkman, J. Tumor dormancy in vivo by prevention of neovascularization. J. Exp. Med., 136: 261-276, 1972.
7. Stan, A. C., Nemati, M. N., Pietsch, T., Walter, G. F., and Dietz, H. In vivo inhibition of angiogenesis and growth of the human U-87 malignant glial tumor by treatment with an antibody against basic fibroblast growth factor. J. Neurosurg., 82: 1044-1052, 1995.
8. Millauer, B., Shawver, L. K., Plate, K. H., Risau, W., and Ullrich, A. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature (Lond.), 367: 576-579, 1994.
9. Moore, K. S., Wehrli, S., Roder, H., Rogers, M., Forrest, J. N., Jr., McCrimmon, D., and Zasloff, M. Squalamine: an aminosterol antibiotic from the shark. Proc. Natl. Acad. Sci. USA, 90: 1354-1358, 1993.
10. Pechulis, A. D., Bellevue, F. H., Cioffi, C. L., Trapp, S. G., Fojtik, J. P., McKitty, A. A., Kinney, W. A., and Frye, L. L. Synthesis of 24ξ-squalamine, an anti-infective steroidal polyamine. J. Org. Chem., 60: 5121-5126, 1995.
11. Moriarity, R. M., Enache, L. A., Kinney, W. A., Allen, C. S., Canary, J. W., Tuladhar, S. M., and Guo, L. Stereoselective synthesis of squalamine desulfate. Tetrahedron Lett., 36: 5139-5142, 1995.
12. Lal, J., Indurti, R., Couraud, P., Goldstein, G., and Laterra, J. Endothelial cell implantation and survival within experimental gliomas. Proc. Natl. Acad. Sci. USA, 91: 9695-9699, 1994.
13. Cahan, M., Walter, K., Colvin, O., and Brem, H. Cytotoxicity of Taxol in vitro against human and rat malignant brain tumors. Cancer Chemother. Pharmacol., 33: 441-444, 1994.
14. McConnell, H. M., Owicki, J. C., Parce, J. W., Miller, D. L., Baxter, G. T., Wada, H. G., and Pitchford, S. The cytosensor microphysiometer: biological applications of silicon technology. Science (Washington DC), 257: 1906-1912, 1992.
15. + exchanger gene family: structure and function studies. Am. J. Physiol., 269: G1-G11, 1995.
16. Tamargo, R. J., Bok, R. A., and Brem, H. Angiogenesis inhibition by minocycline. Cancer Res., 51: 672-675, 1991.
17. Brem, H., and Folkman, J. Inhibition of tumor angiogenesis mediated by cartilage. J. Exp. Med., 141: 427-439, 1975.
18. Passaniti, A. Extracellular matrix-cell interactions: Matrigel and complex cellular pattern formation. Lab. Invest., 67: 804-808, 1992.
19. Weingart, J. D., Sipos, E. P., and Brem, H. The role of minocycline in the treatment of intracranial 9L glioma. J. Neurosurg., 82: 635-640, 1995.
20. Weidner, N., Semple, J. P., Welch, W. R., and Folkman, J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N. Engl. J. Med., 324: 1-8, 1991.
21. + exchanger isoform, NHE-3. American Gastroenterological Association, New Orleans, LA, 1996.
22. Folkman, J. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis [see comments]. N. Engl. J. Med., 333: 1757-1763, 1995.
23. Plate, K. H., Breier, G., and Risau, W. Molecular mechanisms of developmental and tumor angiogenesis. Brain Pathol., 4: 207-218, 1994.
24. Brooks, P. C., Montgomery, A. M., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., and Cheresh, D. A. Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell, 79: 1157-1164, 1994.
25. Sipos, E. P., Tamargo, R. J., Weingart, J. D., and Brem, H. Inhibition of tumor angiogenesis. Annu. NY Acad. Sci., 732: 263-272, 1994.
26. Ingber, D., Fujita, T., Kishimoto, S., Sudo, K., Kanamaru, T., Brem, H., and Folkman, J. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature (Lond.), 348: 555-557, 1990.
27. Fotsis, T., Pepper, M., Adlercreutz, H., Fleischmann, G., Hase, T., Montesano, R., and Schweigerer, L. Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc. Natl. Acad. Sci. USA, 90: 2690-2694, 1993.
28. Ashino-Fuse, H., Takano, Y., Oikawa, T., Shimamura, M., and Iwaguchi, T. Medroxyprogesterone acetate, an anti-cancer and anti-angiogenic steroid, inhibits the plasminogen activator in bovine endothelial cells. Int. J. Cancer, 44: 859-864, 1989.
29. O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H., and Folkman, J. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma [see comments]. Cell, 79: 315-328, 1994.
30. Fotsis, T., Zhang, Y., Pepper, M. S., Adlercreutz, H., Montesano, R., Nawroth, P. P., and Schweigerer, L. The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth. Nature (Lond.), 368: 237-239, 1994.
31. Ingber, D. E. Extracellular matrix as a solid-state regulator in angiogenesis: identification of new targets for anti-cancer therapy. Semin. Cancer Biol., 3: 57-63, 1992.
32. Alliegro, M. C., and Wright, D. A. Polyspermy inhibition in the oyster, Crassostrea virginica. J. Exp. Zool., 227: 127-137, 1983.
33. Allen, W. E., and Wilson, D. J. Early embryonic angiogenesis in the chick area vasculosa. J. Anat., 183: 579-585, 1993.
34. Yuan, F., Chen, Y., Dellian, M., Safabakhsh, N., Ferrara, N., and Jain, R. K. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/ vascular permeability factor antibody. Proc. Natl. Acad. Sci. USA, 93: 14765-14770, 1996.
35. Sanders, R. Inhibition of oxygen-induced retinopathy in the mouse by squalamine. International Conference on Retinopathy of Prematurity, Chicago, 1996.